Inhibition of Polymorphonuclear Leukocyte–Mediated Graft Damage Synergizes With Short-Term Costimulatory Blockade to Prevent Cardiac Allograft Rejection

Background—The early inflammatory response during reperfusion of cardiac allografts is initiated by the infiltration of polymorphonuclear leukocytes (PMNs) into the graft. The impact of early PMN infiltration on allograft rejection compared with long-term graft survival remains poorly understood. Methods and Results—We tested the role of CXCR2, the receptor for 2 PMN attractant chemokines, KC/CXCL1 and MIP-2/CXCL2, on intragraft inflammation and vascularized cardiac allograft rejection in a murine model. Compared with allografts retrieved from control recipients, both PMN infiltration and intragraft proinflammatory cytokine expression were significantly attenuated in allografts from CXCR2-antisera–treated wild-type or from CXCR2−/− recipients. Adoptive transfer of alloantigen-primed T cells rapidly infiltrated and rejected allografts in control recipients, but T-cell infiltration was significantly decreased in recipients depleted of PMNs at transplantation. The influence of early PMN-mediated inflammation on the therapeutic efficacy of costimulatory blockade to prevent allograft rejection was tested. Short-term treatment of recipients with anti-CD154 mAb or CTLA-4 Ig induced modest prolongation of cardiac allograft survival. However, CD154 mAb or CTLA-4 Ig treatment, combined with either peritransplantation PMN depletion or antibodies specific for KC/CXCL1 plus MIP-2/CXCL2, prolonged cardiac allograft survival beyond 100 days. Conclusions—Results suggest that strategies attenuating PMN-mediated tissue damage during reperfusion significantly improve the efficacy of short-term costimulatory blockade to prevent T-cell–mediated rejection of cardiac allografts.

[1]  F. Celada,et al.  CD8 memory T cells: cross-reactivity and heterologous immunity , 2004, Seminars in Immunology.

[2]  R. Fairchild,et al.  Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis. , 2004, The American journal of pathology.

[3]  E. Wherry,et al.  Heterologous immunity provides a potent barrier to transplantation tolerance. , 2003, The Journal of clinical investigation.

[4]  M. Burdick,et al.  Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. , 2002, The Journal of clinical investigation.

[5]  K. Kamiński,et al.  Oxidative stress and neutrophil activation--the two keystones of ischemia/reperfusion injury. , 2002, International journal of cardiology.

[6]  R. Fairchild,et al.  Chemokines: directing leukocyte infiltration into allografts. , 2002, Current opinion in immunology.

[7]  M. Oz,et al.  Suppression of Murine Cardiac Allograft Arteriopathy by Long-Term Blockade of CD40-CD154 Interactions , 2002, Circulation.

[8]  D. Remick,et al.  Neutralization of Groα and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury , 2001 .

[9]  M. Burdick,et al.  Monokine Induced by IFN-γ Is a Dominant Factor Directing T Cells into Murine Cardiac Allografts During Acute Rejection1 , 2001, The Journal of Immunology.

[10]  D. Remick,et al.  Early Chemokine Cascades in Murine Cardiac Grafts Regulate T Cell Recruitment and Progression of Acute Allograft Rejection1 , 2001, The Journal of Immunology.

[11]  D. Remick,et al.  Differential local and systemic regulation of the murine chemokines KC and MIP2. , 2001, Shock.

[12]  R. Fairchild,et al.  CD4+ and CD8+ T Cell Priming for Contact Hypersensitivity Occurs Independently of CD40-CD154 Interactions1 , 2001, The Journal of Immunology.

[13]  D. Remick,et al.  Ratio of local to systemic chemokine concentrations regulates neutrophil recruitment. , 2001, The American journal of pathology.

[14]  M. Wilhelm,et al.  Molecular and cellular events associated with ischemia/reperfusion injury. , 2000, Annals of transplantation.

[15]  D. Bullard,et al.  Leukocyte and endothelial cell adhesion molecules in a chronic murine model of myocardial reperfusion injury. , 2000, American journal of physiology. Heart and circulatory physiology.

[16]  P. Libby,et al.  Host CD40 Ligand Deficiency Induces Long-Term Allograft Survival and Donor-Specific Tolerance in Mouse Cardiac Transplantation But Does Not Prevent Graft Arteriosclerosis1 , 2000, The Journal of Immunology.

[17]  C. Larsen,et al.  Vigorous Allograft Rejection in the Absence of Danger1 , 2000, The Journal of Immunology.

[18]  K. Matsushima,et al.  International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.

[19]  Stefania Gallucci,et al.  Natural adjuvants: Endogenous activators of dendritic cells , 1999, Nature Medicine.

[20]  F. Delmonico,et al.  Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. , 1999, Transplantation.

[21]  L. Turka,et al.  The role of T-cell costimulatory activation pathways in transplant rejection. , 1998, The New England journal of medicine.

[22]  R. Guttmann,et al.  Effects of initial ischemia/reperfusion injury on the transplanted kidney. , 1997, Transplantation.

[23]  C. Larsen,et al.  The CD40 pathway in allograft rejection, acceptance, and tolerance. , 1997, Current opinion in immunology.

[24]  H. Brady,et al.  Leukocytes, cell adhesion molecules and ischemic acute renal failure. , 1997, Kidney international.

[25]  J. Bluestone,et al.  The Complexities of T‐Cell Co‐stimulation: CD28 and Beyond , 1996, Immunological reviews.

[26]  P. Linsley,et al.  Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways , 1996, Nature.

[27]  I. Penn.  Malignant melanoma in organ allograft recipients. , 1996, Transplantation.

[28]  C. Orosz,et al.  Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-alpha or IL-4 and is not required for allograft rejection. , 1995, The American journal of pathology.

[29]  S. Fuggle,et al.  VARIATION IN EXPRESSION OF ENDOTHELIAL ADHESION MOLECULES IN PRETRANSPLANT AND TRANSPLANTED KIDNEYS‐CORRELATION WITH INTRAGRAFT EVENTS , 1993, Transplantation.

[30]  B. Hall,et al.  Cells mediating allograft rejection. , 1991, Immunological reviews.

[31]  C. Smith,et al.  Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  P. Morris,et al.  Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection , 1990, The Journal of experimental medicine.

[33]  B. Myers,et al.  Cyclosporine-associated chronic nephropathy. , 1984, The New England journal of medicine.

[34]  R. Corry,et al.  PRIMARILY VASCULARIZED ALLOGRAFTS OF HEARTS IN MICE: THE ROLE OF H‐2D, H‐2K, AND NON‐H-2 ANTIGENS IN REJECTION , 1973, Transplantation.

[35]  Melvin Cohn,et al.  A Theory of Self-Nonself Discrimination , 1970, Science.

[36]  三浦 正義.  Monokine induced by IFN-γ is a dominant factor directing T cells into murine cardiac allografts during acute rejection , 2003 .

[37]  D. Remick,et al.  Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. , 2001, The American journal of pathology.

[38]  A. Singer,et al.  Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. , 1992, Annual review of immunology.